E-cadherin loss in RMG-1 cells inhibits cell migration and its regulation by Rho GTPases

Area of Science:

• Cell Biology
• Cancer Research
• Molecular Oncology

Background:

• E-cadherin, an adherens junction protein, is vital for epithelial cell contacts.
• Its downregulation is linked to epithelial-mesenchymal transition (EMT) and cancer progression.
• However, E-cadherin's precise role in specific cancers remains complex.

Purpose of the Study:

• To investigate the specific role of E-cadherin in ovarian cancer RMG-1 cells.
• To utilize the CRISPR/Cas9n system for precise E-cadherin knockout (EcadKO).
• To elucidate E-cadherin's function beyond its known roles in cell adhesion.

Main Methods:

• Development of E-cadherin-knockout (EcadKO) RMG-1 ovarian cancer cells using CRISPR/Cas9n.
• Analysis of adherens junctions, cell clustering, and cell-ECM interactions.
• Assessment of beta-catenin levels, cyclin D1 expression, and cell migration.

Main Results:

• EcadKO RMG-1 cells showed complete loss of adherens junctions and cell clustering.
• Increased cell-ECM interactions, with integrin beta1 upregulation and collagen 4 downregulation.
• Decreased beta-catenin and cyclin D1 levels, and significantly reduced cell migration.
• Diminished cellular response to Rho GTPase inhibitors.

Conclusions:

• E-cadherin is essential for beta-catenin expression and transcription in RMG-1 cells.
• E-cadherin regulates Rho GTPase-dependent cell migration.
• The study clarifies E-cadherin's complex role in ovarian cancer RMG-1 cells, highlighting its importance in migration and signaling pathways.